intepirdine (SB-742457) - Roivant
Axovant: Jefferies London Healthcare Conference 2016 (Jefferies 2016 London Healthcare Conference, Axovant) - Nov 19, 2016 - Anticipated patent protection related to composition of matter until 2029; Anticipated patent life extension until 2036 
Anticipated patent expiry Alzheimer's Disease
http://investors.axovant.com/~/media/Files/A/Axovant-IR/presentations-and-publications/20161116-axovant-jefferies-conference.pdf
 
Nov 19, 2016
 
 
e7346030-b982-49bb-a788-5383024fba4b.jpg